{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:01:30Z","timestamp":1791097290136,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.expneurol.2011.08.014","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T02:49:26Z","timestamp":1314845366000},"page":"1-6","source":"Crossref","is-referenced-by-count":86,"title":["Neuroprotective and metabolic effects of resveratrol: Therapeutic implications for Huntington's disease and other neurodegenerative disorders"],"prefix":"10.1016","volume":"232","author":[{"given":"Giulio Maria","family":"Pasinetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Marambaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ferruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay Alexis","family":"Knable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lap","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.08.014_bb0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1079\/BJN20061810","article-title":"Distribution of [3H]trans-resveratrol in rat tissues following oral administration","volume":"96","author":"Abd El-Mohsen","year":"2006","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: the in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.expneurol.2011.08.014_bb0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1747-0285.2009.00901.x","article-title":"Resveratrol is not a direct activator of SIRT1 enzyme activity","volume":"74","author":"Beher","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0025","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1074\/jbc.M501250200","article-title":"Mechanism of human SIRT1 activation by resveratrol","volume":"280","author":"Borra","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Canto","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"issue":"20","key":"10.1016\/j.expneurol.2011.08.014_bb0035","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1007\/s00018-010-0454-z","article-title":"AMP-activated protein kinase and its downstream transcriptional pathways","volume":"67","author":"Canto","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Canto","year":"2009","journal-title":"Nature"},{"issue":"Suppl. 4","key":"10.1016\/j.expneurol.2011.08.014_bb0045","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/ijo.2008.124","article-title":"The regulation of AMP-activated protein kinase by upstream kinases","volume":"32","author":"Carling","year":"2008","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"16","key":"10.1016\/j.expneurol.2011.08.014_bb0050","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","article-title":"Impaired PGC-1\u03b1 function in muscle in Huntington's disease","volume":"18","author":"Chaturvedi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0055","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer's disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0065","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1073\/pnas.0610068104","article-title":"Resveratrol stimulates AMP kinase activity in neurons","volume":"104","author":"Dasgupta","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.expneurol.2011.08.014_bb0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"2007","journal-title":"Cell"},{"issue":"5334","key":"10.1016\/j.expneurol.2011.08.014_bb0075","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuritis in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.08.014_bb0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2010.06.020","article-title":"SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10","volume":"142","author":"Donmez","year":"2010","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.expneurol.2011.08.014_bb0085","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2011.08.014_bb0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","article-title":"Recent progress in the biology and physiology of sirtuins","volume":"460","author":"Finkel","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2011.08.014_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20091372","article-title":"Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP","volume":"426","author":"Fogarty","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1474-9726.2009.00459.x","article-title":"Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans","volume":"8","author":"Greer","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.expneurol.2011.08.014_bb0105","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0110","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","article-title":"Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation","volume":"11","author":"Hawley","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1586\/epr.10.69","article-title":"Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding","volume":"7","author":"Ho","year":"2010","journal-title":"Expert Rev. Proteomics"},{"issue":"1","key":"10.1016\/j.expneurol.2011.08.014_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2009-0916","article-title":"Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration","volume":"16","author":"Ho","year":"2009","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2011.08.014_bb0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","article-title":"Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease","volume":"225","author":"Ho","year":"2010","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.expneurol.2011.08.014_bb0130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/1940-6207.CAPR-11-0148","article-title":"Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases -- safety, pharmacokinetics, and pharmacodynamics","volume":"4","author":"Howells","year":"2011","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.expneurol.2011.08.014_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature01960","article-title":"Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan","volume":"425","author":"Howitz","year":"2003","journal-title":"Nature"},{"issue":"Pt 7","key":"10.1016\/j.expneurol.2011.08.014_bb0140","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/brain\/awm107","article-title":"Beyond digust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease","volume":"130","author":"Johnson","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.08.014_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","article-title":"Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease","volume":"54","author":"Karuppagounder","year":"2009","journal-title":"Neurochem. Int."},{"issue":"5","key":"10.1016\/j.expneurol.2011.08.014_bb0150","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1017\/S0007114509992364","article-title":"Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment","volume":"103","author":"Krikorian","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","article-title":"Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms","volume":"17","author":"Kumar","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0160","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2011.08.014_bb0165","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/sj.cdd.4402219","article-title":"Bax-inhibiting peptide protects cells from polyglutamine toxicity caused by Ku70 acetylation","volume":"14","author":"Li","year":"2007","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.expneurol.2011.08.014_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ng0592-99","article-title":"The Huntington's disease candidate region exhibits many different haplotypes","volume":"1","author":"MacDonald","year":"1992","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.expneurol.2011.08.014_bb0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/hmg\/ddq460","article-title":"ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease","volume":"20","author":"Maher","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0180","doi-asserted-by":"crossref","first-page":"37377","DOI":"10.1074\/jbc.M508246200","article-title":"Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides","volume":"280","author":"Marambaud","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","article-title":"PGC-1alpha, a new therapeutic target in Huntington's disease?","volume":"127","author":"McGill","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.expneurol.2011.08.014_bb0190","first-page":"185","article-title":"Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area","volume":"153","author":"Orgogozo","year":"1997","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.expneurol.2011.08.014_bb0195","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1074\/jbc.M109.088682","article-title":"SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1","volume":"285","author":"Pacholec","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1534","article-title":"Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons","volume":"37","author":"Parker","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2008.06.011","article-title":"Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span","volume":"8","author":"Pearson","year":"2008","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.expneurol.2011.08.014_bb0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mds.870050202","article-title":"Huntington's disease in Venezuela: 7years of follow-up on symptomatic and asymptomatic individuals","volume":"5","author":"Penney","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0215","article-title":"Grape-seed polyphenolic extract improves the eye phenotype in a Drosophila model of tauopathy","volume":"2010","author":"Pfleger","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-10411","article-title":"Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus)","volume":"10","author":"Qin","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0225","doi-asserted-by":"crossref","first-page":"21745","DOI":"10.1074\/jbc.M602909200","article-title":"Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction","volume":"281","author":"Qin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1755-5949.2008.00045.x","article-title":"Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases","volume":"14","author":"Rocha-Gonzalez","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0235","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: a long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0240","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.expneurol.2011.08.014_bb0245","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.neuropsychologia.2006.12.015","article-title":"Verbal episodic memory declines prior to diagnosis in Huntington's disease","volume":"45","author":"Solomon","year":"2007","journal-title":"Neuropsychologia"},{"issue":"6555","key":"10.1016\/j.expneurol.2011.08.014_bb0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/378403a0","article-title":"Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias","volume":"378","author":"Trottier","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.expneurol.2011.08.014_bb0255","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/db09-0482","article-title":"AMPK-deficient mice are resistant to the metabolic effects of resveratrol","volume":"59","author":"Um","year":"2009","journal-title":"Diabetes"},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2011.08.014_bb0260","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1471-2202-9-S2-S6","article-title":"Therapeutic potential of resveratrol in Alzheimer's disease","volume":"9","author":"Vingtdeux","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0265","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","article-title":"AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism","volume":"285","author":"Vingtdeux","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0270","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.2741\/3460","article-title":"Targeting the AMPK pathway for the treatment of type 2 diabetes","volume":"14","author":"Viollet","year":"2009","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.expneurol.2011.08.014_bb0275","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","article-title":"Bioavailability of resveratrol","volume":"1215","author":"Wale","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.expneurol.2011.08.014_bb0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin. Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2011.08.014_bb0290","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.04-3182fje","article-title":"Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J."},{"issue":"13","key":"10.1016\/j.expneurol.2011.08.014_bb0295","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1096\/fj.06-6281com","article-title":"Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease","volume":"20","author":"Wang","year":"2006","journal-title":"FASEB J."},{"issue":"25","key":"10.1016\/j.expneurol.2011.08.014_bb0300","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1523\/JNEUROSCI.0364-08.2008","article-title":"Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0305","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.bbapap.2009.11.015","article-title":"The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology","volume":"1804","author":"Wang","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.expneurol.2011.08.014_bb0310","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2478\/v10134-010-0022-y","article-title":"Potential application of grape derived polyphenols in Huntington's disease","volume":"1","author":"Wang","year":"2010","journal-title":"Transl. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2011.08.014_bb0315","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mnfr.200500003","article-title":"Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats","volume":"49","author":"Wenzel","year":"2005","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.expneurol.2011.08.014_bb0320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1\u03b1 in Huntington's disease neurodegeneration","volume":"5","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.expneurol.2011.08.014_bb0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T18:45:15Z","timestamp":1560537915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611002792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0014488611002792"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.08.014","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}